Disease/Infection News

RSS

CEVEC, Pevion Biotech sign license option agreement for transient CAP-T cell expression technology

CEVEC Pharmaceuticals, the German developer of a novel human expression system derived from amniocytes, announced today the signing of an exclusive license option agreement with Pevion Biotech, the Swiss vaccine company. The agreement enables Pevion Biotech to exclusively use CEVEC's transient CAP-T™ cell expression technology to manufacture and commercialize a protein antigen for vaccination against a widespread human infectious disease.

26 May 2010

MedMira obtains NHS Supply Chain listing for Reveal Rapid HIV Test in the UK

MedMira Inc., a developer of rapid diagnostic technology and solutions, today announced that the Company's Reveal Rapid HIV Test is now one of three rapid HIV tests listed by the National Health Services Supply Chain in the United Kingdom, and the only one able to address both point of care and laboratory testing requirements.

26 May 2010

Researchers present more findings for microbicides, prep at M2010 conference

Researchers on Monday at the International Microbicides Conference in Pittsburgh continued to present data on HIV prevention research, Reuters reports. The news service outlines several prevention methods being researched, including an intravaginal ring that over time releases two antiretrovirals - dapivirine and maraviroc - for up to a month, and a vaginal tablet that time-releases the antiretrovirals dapivirine and DS003 for up to 12 hours.

26 May 2010

AHF urges Obama to address growing ADAP crisis

As many states across the nation face budget and funding shortfalls that are crippling their lifesaving AIDS Drug Assistance Programs (ADAPs), AIDS Healthcare Foundation (AHF), the largest global AIDS organization, is urging President Barack Obama to redirect a portion of unspent stimulus funds in the Health and Human Services Department in order to address the growing ADAP crisis.

26 May 2010

G7 aid delivers 'impressive results,' commitment falls short of 2005 pledge

According to an annual ONE report, which tracks progress on aid commitments made at the 2005 G8 summit in Gleneagles, Scotland, the G7 - Canada, France, Germany, Italy, Japan, the United Kingdom and the U.S. - is "on track to deliver 61 percent of their combined commitments to sub-Saharan Africa, or $13.7 billion of the $22.6 billion increase they promised," allAfrica.com reports.

26 May 2010

Vertex reports 75% patients with HCV achieve viral cure with 12-week telaprevir-based combination regimen

Vertex Pharmaceuticals Incorporated today announced that 75% of people chronically infected with genotype 1 hepatitis C virus (HCV) who had not previously been treated achieved a sustained viral response (SVR or viral cure) after receiving a 12-week telaprevir-based combination regimen, followed by treatment with pegylated-interferon and ribavirin alone, in the Phase 3 ADVANCE trial.

26 May 2010

Experts warn increasing IDUs in eastern, southern Africa could threaten HIV/AIDS fight

An increase in the number of injection drug users (IDUs) in eastern and southern Africa stands to harm efforts to control the spread of HIV/AIDS in the region, warned experts gathered at the World Forum Against Drug conference in Sweden on Monday, Agence France-Presse reports.

26 May 2010

Osteopathic manipulative medicine reduces length of hospital stays for pneumonia patients: Research

Older patients battling pneumonia spent less time in the hospital when treated using osteopathic manipulative medicine - a drug-free form of hands-on medical care focusing on increasing muscle motion - in addition to conventional care, recently published research shows.

26 May 2010

Dangerous bacterium appears in Australia for the first time

Clostridium difficile is a bacterium that has killed thousands abroad. Now is has been detected in three Australians for the first time. The bacterium was detected in three patients at Melbourne's Epworth Hospital.

25 May 2010

Vical receives $4.0M grant to support development of novel vaccine for CMV infection

Vical Incorporated announced today that the company is collaborating with leading pediatric infectious disease researchers Stuart P. Adler, M.D., and Michael A. McVoy, Ph.D., of Virginia Commonwealth University under a five-year, approximately $4.0 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

25 May 2010

Influenza A(H1N1) appears milder than seasonal flu in tropical environment: Report

In a tropical environment, influenza A(H1N1) appeared milder than seasonal flu, was less likely to cause fever and upset stomach and more likely to infect younger individuals, according to a report in the May 24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

25 May 2010

Family of EPA-registered disinfecting products to be launched

An innovative family of EPA-registered disinfecting products will be launched through a new direct selling company, it was announced today.

25 May 2010

New research finding may change direction of vaccine research for M. tuberculosis

Scientists at NYU Langone Medical Center have discovered that the strategy of "immune evasion" common to many viruses, bacteria and parasites, is uncommon to M. tuberculosis where the antigens remain strikingly unchanged and homogenous. The study published in Nature Genetics on May 23, 2010, suggests that M. tuberculosis antigens do not mutate because they hope to be recognized by the body's immune system- perhaps because the host immune mechanism that leads to the typical lung destruction and cough can contribute to the spread of the disease.

25 May 2010

Biomagnetics Diagnostics presents new series of videos on world's first handheld Integrated Optical Biosensor

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced the availability of a new series of video taped interviews of CEO, Clayton Hardman where he presents the world's first handheld Integrated Optical Biosensor (IOBS), which was recently licensed under an agreement with Los Alamos National Security LLC.

25 May 2010

WHA endorses interim targets to eradicate measles as WHO warns disease on the rise

"Measles is making a rapid comeback in African, Asian and even some European countries despite being easily avoided through vaccination, the World Health Organization said Friday as countries pledged to sharply cut infections and deaths worldwide by 2015," the Associated Press reports (Jordans, 5/22). On the final day of the 63rd Annual World Health Assembly, the assembly endorsed a series of interim targets towards the global eradication of measles, VOA News reports.

25 May 2010

Joint research by UB and CDC could lead to new generation of antiviral medicines

Future pandemics of seasonal flu, H1N1 and other drug-resistant viruses may be thwarted by a potent, immune-boosting payload that is effectively delivered to cells by gold nanorods, report scientists at the University at Buffalo and the U.S. Centers for Disease Control and Prevention. The work is published in the current issue of the Proceedings of the National Academy of Sciences.

25 May 2010

MFSI awarded series of new patents for identifying air-borne pathogens

Microfluidic Systems, a privately-held company, announced today it has been awarded a series of new patents covering both the components and integrated systems that perform fully automated sample collection through identification of air-borne pathogens such as bacteria, viruses, and toxins. Patent number 7,705,739 entitled "Integrated Airborne Substance Collection and Detection System" covers a combined instrument in which a detect-to-warn component is integrated with a detect-to-treat system.

25 May 2010

Natural anti-inflammatory protein effective against meningitis-causing bacteria

A study published online on May 24th in the Journal of Experimental Medicine (www.jem.org) suggests that boosting the abundance of one of the body's own proteins might be more effective than antibiotic treatment at fighting off a common meningitis-causing bacterium (E. coli K1).

25 May 2010

Pregnant women with H1N1 flu strain are at risk for obstetrical complications: Study

Pregnant women who contract the H1N1 flu strain are at risk for obstetrical complications including fetal distress, premature delivery, emergency cesarean delivery and fetal death, according to a report in the May 24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

25 May 2010

Media outlets highlight studies presented at International Microbicides Conference

A study in Africa, presented Sunday at the International Microbicides Conference (M2010) in Pittsburgh, has shown that a man's risk of HIV infection doubles if his HIV-positive partner is pregnant, according to HealthDay News/U.S. News & World Report.

25 May 2010

Disease/Infection News

CEVEC, Pevion Biotech sign license option agreement for transient CAP-T cell expression technology

MedMira obtains NHS Supply Chain listing for Reveal Rapid HIV Test in the UK

Researchers present more findings for microbicides, prep at M2010 conference

AHF urges Obama to address growing ADAP crisis

G7 aid delivers 'impressive results,' commitment falls short of 2005 pledge

Vertex reports 75% patients with HCV achieve viral cure with 12-week telaprevir-based combination regimen

Experts warn increasing IDUs in eastern, southern Africa could threaten HIV/AIDS fight

Osteopathic manipulative medicine reduces length of hospital stays for pneumonia patients: Research

Dangerous bacterium appears in Australia for the first time

Vical receives $4.0M grant to support development of novel vaccine for CMV infection

Influenza A(H1N1) appears milder than seasonal flu in tropical environment: Report

Family of EPA-registered disinfecting products to be launched

New research finding may change direction of vaccine research for M. tuberculosis

Biomagnetics Diagnostics presents new series of videos on world's first handheld Integrated Optical Biosensor

WHA endorses interim targets to eradicate measles as WHO warns disease on the rise

Joint research by UB and CDC could lead to new generation of antiviral medicines

MFSI awarded series of new patents for identifying air-borne pathogens

Natural anti-inflammatory protein effective against meningitis-causing bacteria

Pregnant women with H1N1 flu strain are at risk for obstetrical complications: Study

Media outlets highlight studies presented at International Microbicides Conference

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Latest News